|
The Role of Emotion in the Development of Psychopathology Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about The Role of Emotion in the Development of Psychopathology conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. The Role of Emotion in the Development of Psychopathology Clinical research trials and The Role of Emotion in the Development of Psychopathology health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including The Role of Emotion in the Development of Psychopathology. The Role of Emotion in the Development of Psychopathology Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a The Role of Emotion in the Development of Psychopathology clinical trial. Human subjects often get the best healthcare possible for their The Role of Emotion in the Development of Psychopathology condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > The Role of Emotion in the Development of Psychopathology  The Role of Emotion in the Development of Psychopathology
The Role of Emotion in the Development of Psychopathology
For Condition: Mood Disorder
Status: Completed
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The dysregulated experience and expression of emotion is implicated in psychiatric disorders associated both with externalizing problems (aggressive, antisocial behaviors) and internalizing problems (anxiety, depression). Adolescence is a critical juncture in the development of these disorders because of the increased incidence and differentiation of clinical problems during this time period. This is a biobehavioral, longitudinal investigation of the role of emotion in the development of psychopathology in adolescence. The focus is on socialization experiences and biological processes that contribute to emotion dysregulation and disorder in male and female youths between 11 and 16 years of age. Groups studied include (1) comorbid externalizers and internalizers, (2) externalizers only, (3) internalizers only, and (4) asymptomatic youth. The adolescents are assessed again two years later, with instruments and paradigms similar to those used at Time 1. One theme pertains to the integration and disconnection of emotions across systems (e.g., physiological and self-report of experience), and how different patterns of emotion relate to psychopathology. A second theme pertains to development changes in how disorders are manifested (e.g., increased differentiation along gender specific pathways). The anticipated number of patient days per year is 240 for adolescents and mothers, and 120 days for fathers.
Details: Dysregulated emotions are central features of psychiatric disorders associated with both externalizing problems (aggressive, antisocial behaviors) and internalizing problems (anxiety, depression). Adolescence is a critical juncture in the development of these disorders because of the increased incidence and differentiation of clinical problems particularly along gender-based lines. This is a biobehavioral, longitudinal investigation of the role of emotion in the development of psychopathology in adolescence. The focus is on socialization experiences and biological processes that contribute to emotion dysregulation and disorder. Younger (11-13) years) and older (14-16 years) male and female adolescents are followed over time to assess outcomes (psychiatric and psychological problems; adaptive functioning). Groups studied include (1) comorbid externalizers and internalizers, (2) externalizers, (3) internalizers, and (4) asymptomatic youth. Longitudinal analyses will examine factors that contribute to continuation, exacerbation, shifts, or improvement in symptoms over time. Time 1 data collection is complete and 30% of Time 2 cases have been seen. The current anticipated number of patient days per year is 150 for adolescents and mothers. Data collection will be completed by January, 2003.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA Subjects and their families will be recruited from the community. Inclusionary criteria will be based on mother and youth report of (a) emotion regulation problems and (b) the presence of subclinical or clinical symptomatology based on broad-band scales of the Youth Self-Report or mother's report of behavior problems. Individuals meeting entry criteria will be offered entry into the study, and others will be notified. EXCLUSION CRITERIA A debilitating physical impairment (e.g., seizure disorder, cerebral palsy, head trauma). Significant intellectual impairment (i.e., IQ less than 70). History of psychosis. Any condition that would impair a participant's ability to respond to the study's paradigms will be excluded from this study at the time of screening.
Total Enrollment: 1200
Location and Contact Information:
National Institute of Mental Health (NIMH)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 970116; 97-M-0116
Study Start Date: May 21, 1997
Record last reviewed: May 19, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001654
Other Mood Disorder Studies:
1. Neuropsychological Evaluation of Psychiatric and Neurological Patients
2. Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders
3. The Effects of Hormones in Postpartum Mood Disorders
4. Neuroimaging of St. John's Wort-Induced Changes of Serotonin Metabolism in Normal Subjects
5. Progestin (progesterone-like hormones) induced dysphoria (depressed mood, irritability, anxiety)
Related Studies:
Other Mood Disorder Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
The Role of Emotion in the Development of Psychopathology
|
|
|
|
|
|
|
|
